Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China
· Delayed Price · Currency is CNY 15.18
+0.28 (1.88%)
At close: Mar 10, 2026
SHE:300233 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,652 | 4,552 | 6,336 | 8,741 | 11,167 | 7,390 | Upgrade
|
| Market Cap Growth | 12.11% | -28.16% | -27.51% | -21.73% | 51.12% | -4.55% | Upgrade
|
| Enterprise Value | 5,359 | 4,269 | 5,949 | 8,638 | 10,916 | 6,954 | Upgrade
|
| Last Close Price | 14.90 | 11.70 | 15.93 | 21.61 | 27.41 | 17.80 | Upgrade
|
| PE Ratio | 75.41 | 23.13 | 36.27 | 31.98 | 103.41 | - | Upgrade
|
| Forward PE | - | 24.24 | 24.24 | 24.24 | 24.24 | 17.09 | Upgrade
|
| PS Ratio | 2.03 | 1.35 | 1.79 | 2.49 | 3.56 | 2.50 | Upgrade
|
| PB Ratio | 1.52 | 1.19 | 1.68 | 2.39 | 3.25 | 2.13 | Upgrade
|
| P/TBV Ratio | 1.80 | 1.40 | 2.00 | 2.77 | 3.79 | 2.51 | Upgrade
|
| P/FCF Ratio | 32.40 | 29.56 | 19.73 | - | 182.94 | 27.00 | Upgrade
|
| P/OCF Ratio | 20.23 | 15.35 | 9.54 | 34.19 | 25.54 | 13.53 | Upgrade
|
| EV/Sales Ratio | 1.92 | 1.26 | 1.68 | 2.46 | 3.48 | 2.35 | Upgrade
|
| EV/EBITDA Ratio | 11.68 | 7.33 | 11.32 | 13.83 | 24.63 | 12.63 | Upgrade
|
| EV/EBIT Ratio | 40.91 | 16.09 | 27.05 | 23.14 | 48.74 | 19.72 | Upgrade
|
| EV/FCF Ratio | 30.72 | 27.72 | 18.52 | - | 178.82 | 25.41 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.14 | 0.15 | 0.18 | 0.19 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 0.83 | 0.88 | 1.05 | 1.03 | 1.46 | 0.74 | Upgrade
|
| Debt / FCF Ratio | 2.18 | 3.35 | 1.73 | - | 10.69 | 1.50 | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.10 | -0.12 | -0.06 | -0.10 | -0.19 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.79 | -0.69 | -0.90 | -0.33 | -0.74 | -1.21 | Upgrade
|
| Net Debt / FCF Ratio | -2.07 | -2.61 | -1.46 | 1.76 | -5.38 | -2.43 | Upgrade
|
| Asset Turnover | 0.52 | 0.59 | 0.60 | 0.63 | 0.61 | 0.56 | Upgrade
|
| Inventory Turnover | 3.18 | 3.76 | 3.84 | 3.98 | 4.57 | 4.76 | Upgrade
|
| Quick Ratio | 1.22 | 1.32 | 1.14 | 0.98 | 1.18 | 1.63 | Upgrade
|
| Current Ratio | 1.75 | 1.84 | 1.48 | 1.36 | 1.51 | 1.93 | Upgrade
|
| Return on Equity (ROE) | 2.12% | 5.46% | 5.20% | 8.05% | 3.56% | -12.73% | Upgrade
|
| Return on Assets (ROA) | 1.52% | 2.88% | 2.34% | 4.20% | 2.73% | 4.16% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.52% | 6.09% | 5.58% | 9.40% | 4.75% | 10.82% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.20% | 6.10% | 5.10% | 9.10% | 5.80% | 9.20% | Upgrade
|
| Earnings Yield | 1.37% | 4.32% | 2.76% | 3.13% | 0.97% | -6.62% | Upgrade
|
| FCF Yield | 3.09% | 3.38% | 5.07% | -1.35% | 0.55% | 3.70% | Upgrade
|
| Dividend Yield | 2.01% | 2.14% | 1.26% | 0.69% | 0.72% | 1.13% | Upgrade
|
| Payout Ratio | 211.95% | 66.91% | 47.80% | 38.33% | 97.41% | - | Upgrade
|
| Buyback Yield / Dilution | -3.16% | 2.53% | -0.84% | 0.17% | 0.60% | 0.76% | Upgrade
|
| Total Shareholder Return | -1.18% | 4.67% | 0.42% | 0.86% | 1.32% | 1.89% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.